Tumour treating fields (200 kHz) concomitant with weekly paclitaxel for platinum-resistant ovarian cancer: Phase III INNOVATE-3/ENGOT-ov50 study von Vergote, I.B., Copeland, L., Monk, B.J., Coleman, R.L., Cibula, D., Sehouli, J., Samartzis, E.P., Radoslaw, M., Martín, A González, Korach, J., Salutari, V., Witteveen, P.O., O’Malley, D.

Volltext

1059TiP - Tumour treating fields (200 kHz) concomitant with weekly paclitaxel for platinum-resistant ovarian cancer: Phase III INNOVATE-3/ENGOT-ov50 study von Vergote, I.B., Copeland, L., Monk, B.J., Coleman, R.L., Cibula, D., Sehouli, J., Samartzis, E.P., Radoslaw, M., Martín, A González, Korach, J., Salutari, V., Witteveen, P.O., O’Malley, D.

Volltext